Senior insider sale
PRESIDENT & CFO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$649.9K
16.22K shares
What this filing means
MORTIMER IAN plans to sell 16.22K shares of XENON PHARMACEUTICALS INC. valued at approximately $649.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2025ACC: 0000950170-25-008446
Officer· PRESIDENT & CFO
Since Sep 2019
16.22K
Shares to sell
$649.9K
Approx. market value
16.22K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Options
Cash
1/23/2025
16.22KTotal acquired16.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Exercise of Options Cash | 16.22K | — |
| Total | 16.22K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16.22K
Market value
$649.9K
1/23/2025
Total
Units
16.22K
Value
$649.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/23/2025 | 16.22K | $649.9K | NASDAQ | Planned |
| Total | 16.22K | $649.9K | ||